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 Introduction:  The endocrine system is essential to the management of homeostasis 
(source 1). The endocrine system is such an integral part of human survival and homeostasis 
because it involves almost every cell, tissue, and organ within the body.  The endocrine system 
functions by the secretion of chemical signals, referred to as hormones, by a collection of cells 
called glands.  These hormones are passed through the blood stream to reach their target, which 
possesses a receptor specific to a given hormone (source 1).  These endocrine glands are not to 
be confused with exocrine glands, which secretes chemical signals through a gland’s duct 
opening to an epidermal surface instead of the bloodstream (source 2).   
Hormones of the endocrine system can be broken down into two general classes (source 
2). First, there are the peptide hormones, which are chains of various amino acids and they 
interact with their target cell through a receptor on the outer membrane of responsive cells.  
Following the binding to an extracellular receptor, a cascade is initiated to generate a second 
messenger, inducing a response in the target cell.  The other class of hormones is the steroid 
hormones, which are synthesized from cholesterol precursors.  Unlike peptide hormones, steroid 
hormones are lipid soluble and pass through the extracellular membrane and bind to a specific 
receptor protein in the cytoplasm or the nucleus.  This receptor–hormone complex then binds to 
the cell’s DNA.  This binding of the receptor protein to the DNA can either increase or decrease 
the transcription of specific mRNA (source 3). 
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 One of the many target tissues that is part of the endocrine system are the gonads.  
Gonads are typically paired organs in animals and they are responsible for producing 
reproductive cells or gametes.  Males possess testes, which produce spermatozoa and the female 
ovaries produce ova (source 4).  The male testes produce the hormone testosterone, which helps 
maintain the secondary sexual characteristics such as growth of the penis and testes, 
development of body and facial hair, deepening of the voice, increased muscle strength, and 
increase in height (source 5).  The ovaries produce the hormones estrogen and progesterone, 
which are also responsible for maintaining the female secondary sexual characteristics as well as 
controlling the menstrual cycle (source 5).  The regulation of the sex hormones is done via the 
hypothalamic-pituitary-gonadal axis.  .   The hypothalamus is located in the middle of the base of 
the brain and it is thought of as the main control center of the endocrine system (source 6).  The 
hypothalamus releases gonadotropin- releasing hormone (GnRH), which affects the anterior 
pituitary gland.  The anterior pituitary has a vascular connection with the hypothalamus called 
the hypophyseal artery (source 6).  The pituitary gland, in response to GnRH releases many 
hormones, two of which are the gonadotropins, leutinizing hormone (LH) and follicle stimulating 
hormone (FSH).  Both FSH and LH are responsible for the release of the previously mentioned 
sex hormones (source 7). 
 The gonadotropin hormones have roles other than stimulating secondary sex 
characteristics.   FSH stimulates Sertoli cells to produce the protein called the androgen 
binding protein, which promotes the process of spermatogenesis thereby creating sperm.  Also, 
FSH promotes the sertoli cells to produce inhibin which acts as a negative feedback mechanism 
on the anteritor pituitary gland, which causes a decrease in the secretion of FSH.  In males, LH 
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stimlutes leydig cells to produce testosterone, which also participates in the negative feedback 
mechanism by acting on the anterior pituitary gland and hypothalamus. 
In a female, estrogen acts as a negative feedback mechanism when the estrogen levels are 
low.  Also, estrogen is involved as a positive feedback mechanism because it is in high 
concentration at the end of the follicular phase and it acts as a positive inducer of the anterior 
pituitary.  This positive feedback causes the anterior pituitary to release more FSH and LH.  This 
in turn causes the ovary to produce more estrogen. This eventual spike in LH causes the 
ovulation of the ovum.  The hormone progesterone is responsible for stimulating vascular 
activity, which prepares the uterus for the implantation of the embryo.  Increasing vasculature of 
the uterus means the thickening of the uterus lining.  After ovulation, the corpus luteum, which is 
the yellow body left over in the ovary after the secondary oocyte is expelled from ovulation, 
begins to secrete progesterone.  However, the corpus luteum is only a temporary structure and 
when it regresses, progesterone levels fall and the thick vascularized lining in the endometrium 
regresses and then sloughs off  (Source 8). 
 Both FSH and LH are responsible for the development of the egg, not just thickening 
of the endometrium and causing the release of the secondary oocyte.  Although there are many 
factors that are involved in the development of the egg and its eventual fertilization, without the 
action of FSH, it would not be possible.  This goes to show that many women who are unable to 
become pregnant might possibly have issues regarding the expression or activity of FSH. For 
example, when women get older and the number of eggs a woman has left is running low, it 
takes a higher amount of FSH to produce an egg (source a).  If a woman is unable to provide 
enough FSH hormone, then she is unable to produce an egg that could be fertilized.  
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 Infertility is a major issue that many women confront.  Unlike men who generate 
sperm cells from puberty until the day they die, women are born with a set number of eggs.  
With a set number of eggs, there is a limited number of opportunities for a woman to get 
pregnant before menopause is reached (Source b).  Menopause is the failure of the ovaries to 
ovulate due to a lack of functional follicles.  Following menopause, women can no longer 
become pregnant and there are many other changes experienced in relation to change in hormone 
levels (source c).  Approximately 15% of couples in the United States have difficulty conceiving 
a child (Source b).  Also, starting at the age of 30 a woman’s probability of conceiving a child 
decreases 3-5% each subsequent year.  The connection between infertility and heightened levels 
of FSH raises the possibility that understanding FSH action in granulosa cells may help women 
who face infertility issues. 
 A hormone secreted from a gland is useless without its receptor.  In order for the 
target tissue to respond to a chemical message, a receptor is necessary to initiate a cascade of 
events to achieve the desired response from the target cell.  FSHR is a member of the G-coupled 
protein receptor (GPCR) family and it is characterized as a transmembrane protein.  FSHR has 7 
domains that span the plasma membrane of the cell and the intracellular portion is coupled to a 
G(s), which starts a signal cascade upon the extracellular portion interacting with FSH (Source 
12).  
 One aspect of the receptor that deserves attention is lipid rafts.  Lipid rafts are 
organized along the membranes that possess highly organized microdomains of lipids that 
influence the distribution of colocalized proteins.  With the phospholipids regions contain lipid 
rafts that are enriched with sphingolipids and cholesterol the saturated fatty acids can pack 
tightly.  This tight arrangement takes away from the typical fluidity of a phospholipids bilayer 
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and it is considered to have more order (Source d).  In these lipid rafts are proteins, which are 
either located in the liquid disordered regions or are partitioned within the ordered raft domains.  
Some examples of such proteins are glycosylphosphatidylinositol (GPI) anchored proteins that 
are attached to the outer leaflet of the membrane and the Src- family tyrosine kinases that are 
anchored to the inner leaflet.  One particularly identifiable raft structure is caveolae, which 
appear as flask-shaped invaginations within the plasma membrane.  Another component of lipid 
rafts is the flotillin molecules, which are non-caveolar proteins that organize and bring together 
the microdomains that compose the actual rafts.  In an attempt to reveal different biochemical 
properties of the lipid raft itself detergent resistant membrane (DRM) components were revealed 
with the extraction by Triton X-100.  Scientists have determined that lipid rafts may only engage 
in membrane activity if its components are clustered together.  These clusters exist on both sides 
of the plasma membrane and flotillins promote this by acting as clustering agents.  In these 
cluster formations specific sets of cell signaling are accomplished (Source E).   
 One of the membrane functions that lipid rafts take part is trafficking.  In regards to 
trafficking, caveolae mediate endocytosis into the cell.  It has been shown that cross-linked GPI 
anchored proteins translocate to caveolae and are eventually endocytosed.  There have also been 
cases where non- enveloped viruses such as SV40 utilize the caveolae as a means to enter the 
cell through endocytosis.  When cholesterol depletion of lipid raft components occurs, the 
endocytosis of objects is redirected to other internalization mechanisms.  With the ability to 
adjust and still be able to endocytize objects, the lipid raft demonstrates plasticity. 
 Lipid rafts’ ability to perform signal transduction is crucial.  Lipid rafts form 
concentrated platforms for receptors that are activated by ligand bonding.  For signaling systems 
like tyrosine kinase signaling, adaptors, enzymes and scaffolds are recruited to the inner part of 
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the cytoplasmic membrane after ligand activation occurs.  Upon receptor activation, the signaling 
complex that is formed is protected from non- raft enzymes that could affect the signaling 
pathway.  An example of a non- raft enzyme is phosphatase.   In the process of raft binding, the 
recruited proteins are in a new environment where the phosphorylation process can be altered by 
local kinases and phosphatases.  The signaling platforms that lipid rafts form amplifies signaling 
the formation of raft clusters.  Raft clusters form through a network of adaptors, scaffolds, and 
anchoring proteins coming together (source F).  Raft clusters from the liquid- disordered lipid 
matrix then insulate the signaling complex that forms.  This formation leads to an amplification 
of cell signaling by creating a high concentration of signaling molecules and by excluding 
undesired modulators.  The process of forming these signaling platforms is described as both 
dynamic and reversible.  These raft clusters can be disassembled by negative modulators or by 
endocytosis, which removes parts of lipid rafts.  The movement of these raft clusters is 
influenced by cytoskeletal infrastructure as well as secondary messengers (source f). 
  Future research regarding lipid rafts involve further understanding both the structure 
and function.  If the structure of rafts can be more specifically identified, then it can be 
understood whether more than one type of raft exists on the cell surfaces of other types of cells.  
In doing so, more raft- associated proteins and lipid composition need to be determined on both 
the exoplasmic and cytoplasmic sides of a particular cell.  The proposed method of further 
identifying lipid rafts involves isolating a single raft or ligand- activated raft.  Although detergent 
leads to lipid raft aggregation, it is not possible to isolate a lipid raft in its preserved state.  A 
method needs to be developed in order for lipid raft structure to be accurately depicted.  Also, 
processes such as cluster formation during signal transduction is not very well understood.  To 
properly understand this process real- time imaging of the assembly of signaling complexes in 
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both normal and cholesterol depletion would be most ideal. Another aspect of lipid rafts that 
needs to be clarified is the caveolae’s function during signal transduction. Some questions 
scientists would like answered include: whether caveoloae enrichment is induced by cluster 
formation, what protein signals are required for caveolar trapping, and how the internalization of 
caveolae is regulated  (source f). 
 Lipid rafts are an important topic of research in regards to FSH receptors.  FSH 
accomplishes its actions including the maturation of an egg and estrogen production by inducing 
gene expression in a target granulose cell via a signaling cascade.  There are numerous signaling 
cascades involved with FSH such as extracellular regulated kinases (ERKs), p38 mitogen- 
activated protein kinases (MAPKs), and phosphatidylinositol- 3 kinase (PI3K).  The upstream 
kinase that seems to responsible for the initiation of signals that lead to gene expression is 
protein kinase A (PKA).  The activity of this kinase includes direct phosphorylation of 
transcription factors such as cAMP, it promotes remodeling of chromatin by phosphorylating 
histone H3, and it enhances the activity of the p38, MAPK, ERK, and PI3K pathways.  Both 
research and accumulating evidence suggests that the initiation of a single pathway is not enough 
activate target gene expression.  Instead, target gene expression is initiated by multiple pathways 
that rely on eachother through cross- talking (source g). 
In our experiments we will analyze the role of lipid rafts in FSH-dependent signal 
transduction by manipulating the lipid raft structure.  MβCD  (Methyl-Beta-Cyclodextrin) is used 
to manipulate the lipid rafts by removing cholesterol, which alters signaling proteins within the 
lipid raft (Krishnan 2004). Other studies have utilized the method of depleting the lipid rafts of 
cholesterol with MβCD  to test the function of lipid rafts (Draber 2002). In our experiment, we 
plan on demonstrating that the manipulation of the lipid rafts will reveal varying amounts of 
Deleted: Methyl-Beta-Cyclodextrin
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                                                                                                                                       Goldman 8
activation of the MAP kinases in response to FSH (Miyoshi 2007) and (Gonzalex- Robayna 
2000).  
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Methods: Our experiment begins with cultivating 293R cells and placing them in 4 of the 6 
wells within each 6-well dish.  We then allow for these cells to grow to the point at which they 
have 80% confluence.   This experiment requires two different 6-well dishes because one dish 
represents cells treated with just Follicle Stimulating Hormone (FSH) (control experiment) and 
the other 6-well dish will represent cells that are treated with MβCD as well as FSH (MβCD 
experiment).  To prepare the media for each experiment, 10mL of serum free media are placed in 
two separate conical tubes.  The conical tube that will be used for MβCD treatment has 66mg of 
MβCD added to create a 5mM concentration.  Prior to adding this media, we must aspirate and 
remove the cell media that the cells were previously bathed in.  After aspiration, 0.9mL of serum 
free media is added to each well of our control experiment and 0.9mL of serum free media with 
MβCD is added to each well of the MβCD experiment.  Next these 6- well dishes are placed in a 
________incubator for an hour.  During the incubation time 5μL of FSH stock is added to 
500μL of both serum free media with the MβCD and to the serum free media without the MβCD.   
Also a lysis buffer is prepared by adding both one tablet a protease inhibitor and one tablet of a 
phosphatase inhibitor to 10mL of Triton-DOC.  Once an hour has passed, the 6 well dishes 
should be retrieved from the incubator so they may be treated with FSH.  The FSH treatment 
begins as soon as 100μL of each experiment’s respective serum free mixed with FSH stock is 
added.  This 100μL FSH solution will only be added to one well at this point in time for each 
experiment.  Following each FSH treatment the 6 well dishes should be placed back in the 
incubator until another FSH treatment is needed.  A timer should be set so that it counts down 
from 30 minutes.  The 6- well dishes will be treated at the following times during the timer’s 
countdown at 15 minutes, 5 minutes, and 0 minutes.  At 0 minutes both 6- well dishes should be 
placed on ice in order to end cell activity in response to FSH.  After the wells are be aspirated 
Deleted:  (carbon dioxide regulated 
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2mL of 1x PBS is added to each well.  After aspiration again, 0.5mL of the prepared lysis buffer 
needs to be added to each well.  The 6- well dishes, at this point, should still be placed on ice.  
After 10 minutes has passed _____ (name of the blue swuegee thingys) are used to scrape the 
surface of each well.  The lysis buffer solution that remains in each well should be pipetted 
around to gather all the cells in a pool located at the bottom of each well upon tilting the 6- well 
dishes.  The cells and the lysis buffer are gather with a pipette tip and placed in their own 
respective microfuge tubes.  After the contents of each well are extracted the contents of each 
microfuge tube representing their respective wells should be dounced with approximately 10 
strokes and the liquid contents are placed back in their original microfuge tube.  After douncing 
the contents from each well, the douncing equipment should be washed with warm water, 
dionized water, and then dried with Kim Wipes.  The microfuge tubes are then paced in a 
centrifuge located in a 4°C cold room and are centrifuged at max speed for 10 minutes.  The 
supernatant is then extracted and placed in new microfuge tubes.    The remaining pellets should 
be saved.  These samples placed in the microfuge tubes are then used to complete a BCA assay.  
Next, 100μL of 2x sample buffer is added to each microfuge tube and then it is boiled in using at 
heat block at 70°C for 5 minutes. 
     To prepare the samples for a Western Blot, a 12.5% resolving gel needs to be created.  In a 
50mL conical tube the following is to be added: 5mL of water (DI), 6.25mL acrylamide, 3.75mL 
4x running buffer, and 150μL 10%SDS.  The final two components are not to be added until the 
Western Blot apparatus is prepared and ready to have resolving gel injected into it.  These two 
final components include 50μL 10% APS (0.1g of APS and 900μL of water (DI)) and 10μL of 
TEMED.  This resolving gel solution is enough to add the appropriate amount to the necessary 
two Western Blot apparatuses.  After 3.5 mL (how much resolving gel should be added to each 
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apparatus) is added, isopropanol is added until it reaches the top of the apparatus.  The resolving 
gel should solidify in 45 minutes.  After solidification, tilt the apparatus to remove excess 
isopropanol and use whantman paper to remove any residual remaining isopropanol.  The next 
step is to prepare the stacking gel which requires 6.1mL of DI water, 1.3 mL of acrylamide, 
2.5mL of 4x stacking gel, 100μL 10% SDS, 50μL of 10% APS, and 20μL of TEMED.  Again, 
both the 10% APS and TEMED should not be added until you are ready to add the stacking gel 
to the apparatus.  Once the stacking gel is injected on top of the solidified layer of resolving gel, 
it should take 45 minutes for the stacking gel to solidify.  The apparatus should be submerged in 
the Western Blot tub and filled with 1x electrophoresis buffer.  Next your samples should be 
loaded into the different wells of the gel.  Typically a protein marker is used in the first well 
followed by the rest of the protein samples.  Once all of the samples are loaded, a power source 
runs a current through the gel.  The voltage should be set at 100V and once the protein markers 
pass the stacking gel, the voltage is increased to 150V.  Once the protein markers have nearly 
reached the bottom of the gel, the power is turned off and the gels are removed.  The gels and p-
membrane are soaked in transfer buffer for 5 minutes.  Prior to soaking the p-membrane in 
transfer buffer, the p-membrane is to be dipped in methanol.  Next, the gel, whatman paper, and 
p-membrane are used to construct a “gel-transfer sandwich,” with 3 pieces of whatman paper, 1 
p-membrane, gel, and 3 pieces whatman paper starting from the bottom.  The whatman paper 
should be dipped in the transfer buffer prior to constructing the “gel-transfer sandwich.”  The 
dimensions of the p-membrane and whatman paper should be 2.5 inches by 3.25 inches.  The 
transfer sandwich is then placed in the transfer apparatus and is set at 15V for 15 minutes.  After 
the transfer is completed, the p- membranes are placed in a sealed freeze-dried food bag with 
20mL of a solution with 5 grams of powdered milk and 100mL of TBST.  The sealed bags are 
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incubated in the cold room over night on top of the belly dancer.  When resuming the experiment 
the following day, the sealed bag should be opened to allow for the removal of the milk solution.  
Next, each blot is probed with its designated primary antibody.  The solution inserted in the new 
freeze-dried bag is 10mL of the TBST and milk mixture and 5μL of its respective primary 
antibody.  The freeze-dried bag containing the probed plots is placed on the belly dancer in the 
fridge overnight.  Prior to placement on the belly dancer, air bubbles should not be present in the 
sealed bag.  The following day, the blots are removed from their respective bags and are washed 
for three rounds with 50mL of TBST for 5 minutes each round.  Next, a secondary antibody is 
prepared with 20mL of TBST and 4μL of antibody.  The solution is mixed and 10mL is placed in 
each separate freeze-dried bag with its own blot.  Once the air bubbles are removed, the blots are 
placed on the belly dancer for another hour.  The blots are then washed with 50mL of TBST 
again for 3 rounds, each lasting 5 minutes.  The blots are removed from their respective freeze-
dried bags and residual solution is shaken off. The blots are then layered on top of a sheet of 
syran wrap.  The luminol kit is used and 2mL of both solutions (solution A and solution B) are 
mixed together in a conicle tube and then are placed evenly on top of each blot.  After 5 minutes 
of the luminal solution interacting with the blots, the blots are ready to be analyzed with the Fuji 
Film Image Reader. 
                                                                                                                                       Goldman 13
Results: We finally got results on our Western Blots when looking for activated p44 MAP 
Kinase.  The image provided in Figure 1 is a 5 min exposure of the Western blot of total p44 on 
the left and phosphorylated p44 on the right.  The numbers located above the blots listed as 30, 
15, 5, and 0 represent the length of time the cells were treated with FSH. There are bands located 
at each lane for the time treatments of 30, 15, 5 and 0 for the blot that tests for total p44.  This 
was a expected result, and for the blot that was testing for phosphorylated p44 we were expecting 
a band to appear in lane representing a 5 minute hormone treatment.  This band can be visualized 
on the blot on Figure 1, but a better image of this band is provided by the 30-minute exposure 
time as seen in Figure 2.    
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Discussion: While running gels that tested for phosphorylated p44 in the pathway of FSHR we 
had difficulty with getting blots that didn’t have high background.  These blots having high 
background looked rather unusual and blotchy (Figure 3). With Western Blots that lacked 
defined bands, we had to figure out what part of Western Blot protocol we needed to change.  
One of the first things we tried to change was the blocking reagent used.  We tried 5% milk, 5% 
BSA, and 3% gelatin as our blocking reagents and neither of these changes provided normal 
blots.  Then we considered decreasing the primary antibody as well as the secondary antibody 
and that didn’t seem to bring success either.  Next, we tried decreasing the secondary antibody 
and that was not the solution to resolving our problem of high background either.  It wasn’t until 
we switched our secondary antibody completely that we finally had success.  The secondary 
antibody we originally were using was called goat-anti-rabbit HRP and so was the new 
secondary antibody we had success with, but the difference was the company that made it.  
Jackson Immunoresearch, West Grove, PA, produced the original secondary antibody that 
provided a blotchy looking blot and the company of the new secondary antibody that we had 
success with was Invitrogen, Carlsbad, CA.  Other research supports our results of activation of 
the p44 pathway.  One research group found that HEK293N cells stimulated the phophorylation 
of Erk (p44) MAP kinases through β-arrestins (Source 8).  After analyzing the signal 
transduction pathway of GPCR to MAPK/Erk we noticed that there are two different pathways 
that lead to Erk (Source 9). One pathway leads to Erk through the internalization of the GPCR 
and the other pathway leads to Erk through camp indirectly activating Erk (Source 9).  We would 
like to question whether FSHRs utilize one or both of these pathways.  Research data lends 
support that activated cAMP, which independently phosphorylates Erk, occurs when the FSHRs 
have a low plasma membrane density (Source 8).  This data has lead us to believe that changing 
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the signal pathway occurs based on changes in the receptor density within the plasma membrane 
(Source 8).  Despite finding data that might answer our questions about the activation of p44 we 
have considered future studies to provide us with conclusive results in regards to determining 
which of the two Erk pathways FSHR takes to eventually activate p44.   
In our future studies determining whether p44 activation takes one pathway instead of the 
other would require us to understand the differences between the two pathways that we are aware 
of.  One pathway to p44 requires the internalization of the GPCR and the other pathway requires 
cAMP to indirectly activate p44.  To test to see if it is just the pathway that uses cAMP to 
indirectly activate p44 we would have to prevent the possibility of the GPCR becoming 
internalized. Preventing the internalization of the GPCR would allow us determine whether p44 
is activated through cAMP indirectly activating p44 because it is the only pathway that can 
possibly lead to p44 activation if internalization of the GPCR is inhibited.  The method in which 
we would run this experiment would occur through downregulation of the GPCRs through 
lysosomal degradation or by removing, blocking, or degrading β-arrestins (Source 10).  
According to this research, β-arrestins and lysosomal degradation could inhibit GPCR 
internalization.  To test for the other potential p44 activation pathway we would have to block 
cAMP.  To inhibit cAMP production, my suggestion would be to activate GPCRs that activate 
the Gi class of Ga subunits that are responsible for inhibiting the cAMP that adenylyl cyclase is 
responsible for producing (Source 11).   By successfully blocking each of the two different p44 
activation pathways we can determine which pathway FSHR signal transduction utilizes.  If there 
is p44 activation in both of these pathways it is likely that FSHR signal transduction utilizes both 
pathways to activate p44. 
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Our future studies also involve making an addition to the methods section of the 
experiments that I recently carried out.  The only change to this section would be treating the 
cells with MβCD in addition to FSH.  FSHRs and their components known as lipid rafts are 
composed of cholesterol and MβCD has the ability to remove cholesterol.  We believe that lipid 
rafts play a vital role in the method of signal transduction pathway of FSHRs.  By destroying the 
integrity of lipid rafts we hypothesize that p44 activation will not occur in MβCD treated cells. 
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